Skin Cancer/Melanoma

New Targets May Improve the Treatment of Rare Skin Cancer

June 16, 2021

While merkel cell carcinoma (MCC) tends to have poor prognoses and limited treatment options, promising response rates with checkpoint inhibitors may pave the way for better treatment for the rare skin cancer.